Buys
Open market- Shares
- +28,000
- Avg price
- $1.24
- Total value
- +$34,620
Sean Ellis - Director at Entera Bio Ltd.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- ENTX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Sean Ellis in Entera Bio Ltd.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +28,000
- Share %
- 100%
- Total value
- +$34,620
Reported holdings for Sean Ellis in Entera Bio Ltd.
Form 4 holding
Director
Entera Bio Ltd.
- Security class
- Ordinary Shares, par value NIS 0.0000769 per share
- Shares / value
- 188,098
- Estimated value
- $231,360
- Report date
- 05 Mar 2026
- Price
- $1.23
- Ownership
- Direct
Form 4 holding
Director
Entera Bio Ltd.
- Security class
- Stock Option (right to buy)
- Shares / value
- 33,505
- Estimated value
- Report date
- 01 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares, par value NIS 0.0000769 per share
- Underlying amount
Transaction history for Sean Ellis in Entera Bio Ltd.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.